Cargando…
Challenges of predicting immune checkpoint therapy responders in lung cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797686/ https://www.ncbi.nlm.nih.gov/pubmed/35116808 http://dx.doi.org/10.21037/tcr.2019.04.07 |
| _version_ | 1784641611411488768 |
|---|---|
| author | Marwitz, Sebastian |
| author_facet | Marwitz, Sebastian |
| author_sort | Marwitz, Sebastian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8797686 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87976862022-02-02 Challenges of predicting immune checkpoint therapy responders in lung cancer Marwitz, Sebastian Transl Cancer Res Editorial Commentary AME Publishing Company 2019-06 /pmc/articles/PMC8797686/ /pubmed/35116808 http://dx.doi.org/10.21037/tcr.2019.04.07 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Editorial Commentary Marwitz, Sebastian Challenges of predicting immune checkpoint therapy responders in lung cancer |
| title | Challenges of predicting immune checkpoint therapy responders in lung cancer |
| title_full | Challenges of predicting immune checkpoint therapy responders in lung cancer |
| title_fullStr | Challenges of predicting immune checkpoint therapy responders in lung cancer |
| title_full_unstemmed | Challenges of predicting immune checkpoint therapy responders in lung cancer |
| title_short | Challenges of predicting immune checkpoint therapy responders in lung cancer |
| title_sort | challenges of predicting immune checkpoint therapy responders in lung cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797686/ https://www.ncbi.nlm.nih.gov/pubmed/35116808 http://dx.doi.org/10.21037/tcr.2019.04.07 |
| work_keys_str_mv | AT marwitzsebastian challengesofpredictingimmunecheckpointtherapyrespondersinlungcancer |